Catalyst Pharmaceuticals board member Philip H. Coelho to retire at 2023 annual meeting

CATALYST PHARMACEUTICALS, INC.

Philip H. Coelho, independent director since 2002, will not stand for reelection.
Coelho serves as Chair of Nominating/Corporate Governance Committee and on Audit Committee.
Retirement is not due to any disagreement with the company.
He will continue as director until term expires at the 2023 annual meeting.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Philip H. Coelho

Director

CPRX · CATALYST PHARMACEUTICALS, INC.

Filed: March 31, 2023, 7:59 PM ET

On March 29, 2023, Philip H. Coelho, an independent member of the Board of Directors (“Board”) of Catalyst Pharmaceuticals, Inc. (the “Company”), advised the Company of his decision not to stand for reelection at the 2023 annual meeting of the Company’s stockholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Philip H. Coelho retired as Director at CATALYST PHARMACEUTICALS, INC..

Action: retired
Role: Director

Exact text from the filing

On March 29, 2023, Philip H. Coelho, an independent member of the Board of Directors (“Board”) of Catalyst Pharmaceuticals, Inc. (the “Company”), advised the Company of his decision not to stand for reelection at the 2023 annual meeting of the Company’s stockholders.

View on SEC.gov

CATALYST PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001193125-23-088225

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.